SSZ - CAS 1262287-23-9

SSZ is a multitarget inhibitor that addresses various pathological mechanisms in Alzheimers disease (AD) . It targets acetylcholinesterase (acetylcholinesterase), butyrylcholinesterase (butyrylcholinesterase), β-site amyloid precursor protein-cleaving enzyme 1 (BACE1), and γ-secretase (γ-secretase) . In murine models, SSZ has been shown to improve Alzheimers disease and exhibit neuroprotective effects.

1262287-23-9

C18H19ClN4

326.82

ClC=1N=C(C=C(C1)C2=CNC=3N=CC=CC32)NC4CCCCC4

-20°C

Ice Packs

Small Compound